Pharma

#AI / data analytics / healthtech / informatics #Carbon emissions #Climate change #Clinical trial design #Comment #Funding #Life sciences #Pharma #Psychedelics #Start-ups

Podcast: The future climate and landscape for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “The future climate and landscape for drug discovery” which covers three written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Pharma’s important climate and What will the… Read More

#News

Innovation
#Advanced Therapies #Animal models #Autoimmune disease #Cell and gene therapy #Data #Genetics / genomics #Immunology #Pharma

New podcast on animal genomics, immunology and CGTs

This is the latest episode of the free DDW narrated podcast, “What’s at the forefront of innovation?” It covers three articles written for the for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Can animal genomics help find… Read More

#News

Cancer cell
#Cancer #Drug development #Oncology #Pharma

Scientific Affairs Group expands to over 200 oncologists  

Drug development company Ellipses Pharma now has more than 200 oncology experts from 106 institutions worldwide providing analysis and advice on selection of the most promising potential cancer medicines in its Scientific Affairs Group (SAG).   The number of experts joining the SAG has increased by 53% in… Read More

#News

European Commission
#Biosimilars #Comment #European Commission #Opinion #Pharma #Regulatory

European Commission vs Big Pharma, or profit vs access?  

On January 31 2023, an internally circulated version of the European Commission’s overhaul of the EU’s pharma legislation was leaked, and published by Politico1. Politico published a summary of the key propositions outlined in the draft2, and DDW’s Multimedia Editor Megan Thomas investigates their intention,… Read More

#Exclusive Content #Opinion #Regulatory

Protesting against health inequalities
#ABPI #Collaboration #Drug discovery #Drug innovation #NHS #Pharma #UK

NHS/industry collaboration could improve access to drugs

Collaborative working between the NHS and industry could reduce variations in uptake of innovative treatments across the UK, a joint report from NHS Confederation and ABPI argues.   Analysis from the report has shown a significant variation in access to innovative medicines for patients across the UK and… Read More

#News

#Carbon emissions #Climate change #Comment #Life sciences #Pharma

Pharma’s important climate

Listen to this article on the DDW podcast: By DDW Editor Reece Armstrong The looming threat of global warming, consequences of which can already be seen and felt across the planet, will impact us all. It seems that despite a constant barrage of warnings by scientists and… Read More

#Exclusive Content #Opinion

Research scientist working in laboratory
#Cancer research #Drug discovery #Oncology #Pharma

Oncology Programme will accelerate cancer drug discovery

Biometrics contract research organisation (CRO) Phastar has joined Lean Life Science’s Oncology Development Programme (ODP2).   The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies.  In collaboration with global pharma companies, Cancer Research… Read More

#Cancer Research #News

#Diversity #Pharma #Pistoia Alliance #Women in Discovery #Women in STEM

Large pharma companies support Women in STEM leadership pilot 

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a pilot for its new Women in STEM leadership programme, which involves 15 large pharma companies that will support diversity in executive roles and advocate a fairer working culture… Read More

#News

Lykke Hinsch Gylvin
#Boehringer Ingelheim #New appointment #Pharma #Pharmaceutical industry

Boehringer boosts pharma division with key appointment

Boehringer Ingelheim has appointed Lykke Hinsch Gylvin as Head of Medicine and Chief Medical Officer, effective November 1, 2022. Most recently, Gylvin served as Vice President, Global Medical Franchise Head, Neuroscience at Novartis. She brings more than 20 years of pharmaceutical experience, ranging from early-stage drug development to post-approval lifecycle… Read More

#Business & Investment #News

#AI #AI / data analytics / healthtech / informatics #Machine learning #Pharma

Intelligent designs: How pharma researchers are using AI 

DDW Editor Reece Armstrong explores how AI is being utilised in the lab and what the technology can really do within pharma.  Artificial intelligence (AI), a branch of computer science encompassing machine learning and deep learning, and which technologies such as automation, natural language processing… Read More

#Business & Investment #Exclusive Content #Opinion #Trends & Analysis

#Diversity #Drug discovery #Pharma #Women in STEM

App exclusive: Women in STEM: how to promote diversity in pharma

In this article exclusive to the Drug Discovery World app, Reece Armstrong speaks to Anca Ciobanu, Consultant and Strategic Theme Lead at the Pistoia Alliance about its Women in STEM pilot programme and some of the barriers women face for progressing through the life sciences sector. The article touches upon… Read More

#Exclusive Content

#Cell culture #High throughput screening #Pharma #SLAS Europe

Anticipating SLAS Europe 2022: Reflections and expectations

Jeremy Simpson is a keynote speaker for SLAS Europe 2022 and shares with Megan Thomas what excites him about this year’s programme and what he hopes the conference will cover, including approaches for standardisation in 3D cell models and new applications of data science. The day-to-day Simpson describes his set… Read More

#Exclusive Content

London, UK
#Avacta #Biologics / Biotechnology #Pharma

Avacta relocates HQ to London campus   

Clinical stage oncology company Avacta Group has moved its Therapeutics division to a new headquarters in London.  The headquarters will be based at Scale Space in Imperial College’s White City Campus, London. Scale Space is part of the broader White City Innovation District. White City is currently… Read More

#News

#Cell culture #Pharma #Start-ups

Taking the next step in cell culture

Félix Lavoie-Pérusse is co-founder and Chief Commercial Officer of Saguaro Technologies. He tells Lu Rahman why the company wants to make drug discovery more successful with its next-generation technologies in cell culture. Saguaro partners with drug discovery scientists to convert potentially disruptive technologies into valuable cell culture products. These… Read More

#Exclusive Content

#Biologics / Biotechnology #Clinical trials #Manufacturing #Pharma

This week in drug discovery (2-6 May)   

Swiss biotech sector sees strong performance in 2021, report says  Switzerland’s life sciences sector saw a strong year in 2021 with companies contributing to the Covid-19 pandemic and high levels of capital investments being key indicators of the sector’s strength.   This is according to the… Read More

#News